Cambridge Investment Research Advisors, Inc. Portfolio Holdings

Cambridge Investment Research Advisors, Inc.

  • $32.9 Billion
  • Q2 2025

Cambridge Investment Research Advisors, Inc. has filed its 13F form on July 31, 2025 for Q2 2025 where it was disclosed a total value porftolio of $32.9 Billion distributed in 3608 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Index Fds S&P 500 ETF with a value of $1.05B, Apple Inc. with a value of $885M, Nvidia Corp with a value of $874M, Invesco Qqq Trust, Series 1 with a value of $729M, and Vanguard Total Stock Market Et with a value of $620M.

Examining the 13F form we can see an increase of $3.25B in the current position value, from $29.6B to 32.9B.

Below you can find more details about Cambridge Investment Research Advisors, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $32.9 Billion
ETFs: $19 Billion
Technology: $3.82 Billion
Financial Services: $1.98 Billion
Consumer Cyclical: $1.21 Billion
Communication Services: $939 Million
Industrials: $892 Million
Healthcare: $851 Million
Consumer Defensive: $755 Million
Other: $1.23 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$11.1B
$683,000 0.0% of portfolio
3,645
Q2 2025 Added 18.92%
Themes ETF Tr Generative
-
$354,000 0.0% of portfolio
-
Q2 2025 Added 27.56%
$1.18B
$474,000 0.0% of portfolio
98,912
Q2 2025 Reduced 1.88%
$5.55B
$724,000 0.0% of portfolio
8,156
Q2 2025 Added 8.63%
$0
$607,000 0.0% of portfolio
30,916
Q2 2025 Reduced 11.4%
$3.31B
$883,000 0.0% of portfolio
20,360
Q2 2025 Reduced 2.44%
$46.9M
$3,000 0.0% of portfolio
10,000
Q1 2023 New
Tidal Tr Ii Yieldmax Amd
-
$191,000 0.0% of portfolio
-
Q2 2025 Added 16.32%
Tidal Tr Ii Yieldmax
-
$353,000 0.0% of portfolio
-
Q2 2025 Reduced 13.66%
Tidal Tr Ii Yieldmax
-
$499,000 0.0% of portfolio
-
Q2 2025 Reduced 21.43%
Tidal Tr Ii Yieldmax
-
$405,000 0.0% of portfolio
-
Q2 2025 Reduced 1.88%
Tidal Trust I Unusual
-
$333,000 0.0% of portfolio
-
Q2 2025 Added 2.69%
$0
$628,000 0.0% of portfolio
31,715
Q2 2025 Reduced 45.97%
Tidal Tr Ii Ret Stckd
-
$1.09 Million 0.0% of portfolio
-
Q2 2025 Reduced 76.15%
Tidal Tr Ii Clockwise
-
$934,000 0.0% of portfolio
-
Q2 2025 Reduced 1.83%
Tidal Tr Ii Yieldmax
-
$396,000 0.0% of portfolio
-
Q2 2025 Added 37.36%
Tidal Tr Ii Yieldmax
-
$218,000 0.0% of portfolio
-
Q2 2025 Reduced 9.48%
Tidal Tr Ii Return Stckd
-
$624,000 0.0% of portfolio
-
Q2 2025 Reduced 75.51%
$789M
$25,000 0.0% of portfolio
60,107
Q2 2025 Reduced 25.85%
$5.72B
$284,000 0.0% of portfolio
3,913
Q2 2025 Added 4.77%
$994M
$271,000 0.0% of portfolio
17,610
Q1 2025 Added 5.0%
$11.1B
$625,000 0.0% of portfolio
14,119
Q2 2025 Reduced 8.43%
$13.6B
$665,000 0.0% of portfolio
2,053
Q2 2025 Reduced 9.8%
Tortoise Capital Series Trus Essential
-
$1.6 Million 0.0% of portfolio
-
Q2 2025 Reduced 1.56%
Tortoise Capital Series Trus
-
$126,000 0.0% of portfolio
-
Q2 2025 New
Tortoise Capital Series Trus North Amern
-
$276,000 0.0% of portfolio
-
Q2 2025 New
$7.82B
$983,000 0.0% of portfolio
13,903
Q2 2025 Reduced 2.08%
$2.44B
$492,000 0.0% of portfolio
14,407
Q2 2025 Reduced 9.86%
$5.1B
$233,000 0.0% of portfolio
4,516
Q2 2025 Reduced 1.5%
$1B
$303,000 0.0% of portfolio
15,594
Q2 2025 Added 0.37%
$0
$1.49 Million 0.0% of portfolio
47,101
Q2 2025 Reduced 8.75%
$813M
$38,000 0.0% of portfolio
27,808
Q2 2025 New
$19.5B
$1.64 Million 0.0% of portfolio
21,575
Q2 2025 Added 12.14%
$0
$531,000 0.0% of portfolio
7,503
Q2 2025 Reduced 24.49%
Trinity Biotech PLC Spons
-
$14,000 0.0% of portfolio
-
Q1 2024 New
$45.3B
$592,000 0.0% of portfolio
10,100
Q2 2025 Reduced 6.96%
$0
$86,000 0.0% of portfolio
12,252
Q2 2025 Reduced 6.7%
$1.57B
$256,000 0.0% of portfolio
4,648
Q1 2025 Reduced 2.72%
$5.17B
$223,000 0.0% of portfolio
9,434
Q2 2025 New
Trisalus Life Sciences
-
$106,000 0.0% of portfolio
-
Q2 2025 Added 25.07%
Trust For Professional Manag Activepassive
-
$1.29 Million 0.0% of portfolio
-
Q2 2025 Added 46.84%
Trust For Professional Manag Activepassive
-
$636,000 0.0% of portfolio
-
Q2 2025 Added 44.78%
Trust For Professional Manag Activepassive
-
$504,000 0.0% of portfolio
-
Q2 2025 Added 21.43%
$0
$381,000 0.0% of portfolio
17,548
Q2 2025 Reduced 7.14%
$2.28B
$996,000 0.0% of portfolio
27,319
Q2 2025 Added 0.01%
Two Hbrs
-
$316,000 0.0% of portfolio
-
Q2 2025 Added 5.78%
$0
$551,000 0.0% of portfolio
24,370
Q2 2025 Added 6.68%
$0
$1.13 Million 0.0% of portfolio
34,469
Q2 2025 Added 1.27%
$0
$1.05 Million 0.0% of portfolio
26,462
Q2 2025 Reduced 0.32%

Summary

  • Portfolio
  • No. of Stocks 3,608
  • Current Value $32.9 Billion
  • Prior Value $29.6 Billion
  • Filing
  • Period Q2 2025
  • Filing Date July 31, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 307 stocks
  • Additional Purchases 1,702 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1,528 stocks
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email